By Sharon AtienoKenya risks a vaccination crisis if the country does not honour its Global Alliance for Vaccines and ...
Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...
Nadofaragene firadenovec intravesical gene therapy continues to show promise in treating BCG-unresponsive NMIBC bladder cancer.
ImmunityBio, Inc. , a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation's largest independent providers of urology and related specialty services, is one of the ...
ImmunityBio, Inc. a annoncé que U.S. Urology Partners est l'un des premiers fournisseurs à participer au programme d'accès ...
People living with HIV are more than 14 times more likely to fall ill with TB disease than people without HIV.
A recent study confirms that the 100-year-old BCG vaccine does not protect against COVID-19, challenging early assumptions ...
Aurobindo, that last year signed a deal with U.S. drugmaker MSD to manufacture one of their biologics products at its ...
Introduction Vaccines are biological preparations that stimulate the immune system to develop protection against specific infectious diseases.
The disease is widespread in poorer countries but an outbreak in global north nations signals a crack in public health ...
Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...
According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...